Dynavax Licenses Coley’s Toll-Like Receptor Adjuvant For Hep B Vaccine Candidate Heplisav
BLA asking approval of one-month, two-dose vaccine regimen anticipated in second half of 2008.
BLA asking approval of one-month, two-dose vaccine regimen anticipated in second half of 2008.